Endoscopic management of recurrent epistaxis: The experience of two metropolitan hospitals in Italy

Minni, Antonio; Dragonetti, Alberto; Gera, Roberto; Barbaro, Marco; Magliulo, Giuseppe; Filipo, Roberto

doi:10.3109/00016481003621538

Cited by 18 publications

(32 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Furthermore, additional three papers were obtained by hand‐searching. Finally, 33 full papers were included in the present study . These data are shown in Table .…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Sphenopalatine artery surgery for refractory idiopathic epistaxis: Systematic review and meta‐analysis

et al. 2019

View full text Add to dashboard Cite

Objectives Epistaxis, especially posterior epistaxis, is occasionally refractory to treatment. In these cases, sphenopalatine artery surgeries, including cauterization and ligation, are required. Previous reports have demonstrated treatment results for these procedures but failed to provide high‐level evidence. The aim of this study was to quantify the rates of failure and perioperative complications of these procedures by using a meta‐analysis technique. Methods We systematically searched electronic databases and identified articles regarding epistaxis, sphenopalatine artery ligation, or cauterization. Pooled rebleeding and complication rates were calculated by using a random effects model. Results A total of 896 cases of sphenopalatine ligation or cauterization for epistaxis were analyzed. Pooled rebleeding rates for the entire cohort, cauterization group, and ligation group were 13.4% (95% confidence interval [CI] 10.0–17.8, P < 0.001), 7.2% (95% CI 4.6–11.0, P < 0.001), and 15.1% (95% CI 9.8–22.5, P < 0.001), respectively. Pooled perioperative complication rates for the entire cohort, cauterization group, and ligation group were 8.7% (95% CI 4.9–15.1, P < 0.001), 10.2% (95% CI 3.8–24.5, P < 0.001), and 6.4% (95% CI 1.8–20.9, P < 0.001), respectively. Conclusion Overall, sphenopalatine surgery for refractory epistaxis is an effective method because of its low rates of failure and complications. Cauterization is more effective than ligation, whereas complications are comparable between the two procedures.Laryngoscope, 129:1731–1736, 2019

show abstract

“…Furthermore, additional three papers were obtained by hand‐searching. Finally, 33 full papers were included in the present study . These data are shown in Table .…”

Section: Resultsmentioning

confidence: 99%

“…The pooled perioperative complication rate was 8.7% (95% CI, 4.9–15.1). The most frequent complication was nasal crusting, which occurred in either 21% or 8% . The second most frequent complication was acute sinusitis and nasal dryness: acute sinusitis occurred in 10% and severe nasal dryness occurred in 10% .…”

Section: Resultsmentioning

confidence: 99%

Sphenopalatine artery surgery for refractory idiopathic epistaxis: Systematic review and meta‐analysis

et al. 2019

View full text Add to dashboard Cite

show abstract

“…The traditional treatment strategy of posterior nasal packing has been largely replaced by the more effective and less morbid techniques of transnasal endoscopic sphenopalatine artery ligation (TESPAL) [1][2][3] and endovascular arterial embolization. [4][5][6] Furthermore, a recent study by Dedhia et al 7 suggested that TESPAL is the most cost-effective strategy compared with posterior nasal packing.…”

mentioning

confidence: 99%

Cost-effectiveness Analysis of Endoscopic Sphenopalatine Artery Ligation vs Arterial Embolization for Intractable Epistaxis

Rudmik

Leung

2014

JAMA Otolaryngol Head Neck Surg

View full text Add to dashboard Cite

show abstract

“…Bu ru nun ko lay ula şı la bi len böl ge le rin de mey da na ge len ve ka na ma nın bol olma dı ğı du rum lar da epis tak si sin kon tro lün de en sık uy gu la nan yön tem lo kal ko te ri zas yon dur. [8][9][10][11][12][13] Kimya sal ya da elek tro ko te ri zas yon ya pı la bi lir. Kim yasal ko te ri zas yon gü müş nit rat çu bu ğu ile ya pı lır.…”

Section: Te Da Vi̇unclassified

“…[21][22][23][24][25][26] Tam po na rağ men de vam eden ka na ma lar da sfe nopa la tin ar ter ve an te ri or et mo i dal ar te rin en dos kopik ko te ri zas yo nu ya pı lır. 13 Sep top las ti, an te ri or ve 1. Has ta nın ha va yo lu, so lu nu mu ve do la şı mı kon trol edil me li 2.…”

Section: 2unclassified

Epistaxis and New Approaches to the Management of Epistaxis: Review

Ugur¹,

Ark²,

Kurtaran³

et al. 2013

Turkish J Rhinology

View full text Add to dashboard Cite

Ö ÖZ ZE ET T Epi tak sis (bu run ka na ma sı), ku lak bu run bo ğaz acil le rin de en sık gö rü len has ta lık lar dan biri dir. Üst so lu num yo lu en fek si yon la rı nın sık lı ğı, ka pa lı me kan la rın faz la ısı tıl ma sı ve nem ye tersiz li ği ne den le riy le ço ğun luk la son ba har ve kış ay la rın da epis tak si sin gö rül me sık lı ğı ar tar. Epis tak sis, sık lık la ken di li ğin den ve ya mü da ha le ile du ran bir ka na ma olup, ba zen de ha ya tı tehdit edi ci ola bi lir. Bu ne den le ku lak bu run bo ğaz he kim le ri nin ve hat ta acil ser vis de gö rev li bü -tün he kim le rin de epis tak si se acil yak la şım ko nu sun da bil gi sa hi bi ol ma sı ge re kir. Sık lı ğı tam ola rak bi lin me mek le bir lik te ço ğu ki şi ha ya tı nın bir dö ne min de epis tak sis ya şa mış tır. An te ri or ve pos te ri or epis tak sis ol mak üze re iki ay rı epis tak sis şek li bu lu nur. En sık kar şı la şı lan epis tak sis, an te ri or epis tak sis dir. Pos te ri or epis tak sis, an te ri or epis tak sis ile kar şı laş tı rıl dı ğın da da ha cid di bir kli nik tab lo ile sey re der. Her yaş gru bun da epis tak si sin et yo lo jik ne den le ri ve lo ka li zas yo nu de ği şir. Ço cuk lar da bu run ka rış tır ma, ye tiş kin ler de trav ma, yaş lı lar da da hi per tan si yon epis taksi sin en sık ne de ni dir. Ta nı da ru tin fi zik mu a ye ne ler le bir lik te en dos ko pik mu a ye ne, kan tet kikle ri ve lü zu mu ha lin de rad yo lo jik gö rün tü le me yön tem le ri (bil gi sa yar lı to mog ra fi, man ye tik re zo nans, an ji yog ra fi) uy gu la na cak yön tem ler dir. Gü nü müz de epis tak sis de ru tin de uy gu la nı lan te da vi le rin ya nı sı ra ge li şen tek no lo ji ve ilaç en düs tri si ile ta nı ve te da vi için de ği şik yön tem ler uy gu lan mak ta dır. Bu der le me de an te ri or ve pos te ri or epis tak si sin; et yo lo ji si, ta nı sı ve te da vi si özet len di. Ay rı ca li te ra tür bil gi le ri ışı ğın da epis tak si sin te da vi sin de ki ye ni lik ler ko nu sun da detay lı bil gi ve ril di.A An na ah h t ta ar r K Ke e l li i m me e l le er r: : Aciller; burun kanaması; etyoloji; tedavi A AB BS S T TR RA AC CT T Epis ta xis (no se ble e ding) is one of the most com mon di se a ses in otor hi no lary go lo gic emer gen ci es. In ci den ce of epis ta xis in cre a ses in win ter and fall months du e to the fre qu ency of upper air way in fec ti ons, ex tre me war med clo sed are as and du e to de fi ci ency of hu mi dity. Epis ta xis is a self-li mi ting di se a se but so me ti mes it can be a li fe thre a te ning di se a se. Thus, oto lary ngo lo gist and al so emer gency ca re doc tors sho uld know abo ut the epis ta xis the rapy ap pro ac hes. The in ci den ce of epis ta xis is not known exactly but every body ha ve epis ta xis on ce in the ir who le li fe. The re are two kinds of epis ta xis; an te ri or and pos te ri or epis ta xis. An te ri or epis ta xis is mo re com mon than pos teri or epis ta xis. Pos te ri or epis ta xis has mo re se ve re cli ni cal pre sen ta ti ons when com pa red to ...

show abstract

Endoscopic management of recurrent epistaxis: The experience of two metropolitan hospitals in Italy

Cited by 18 publications

References 15 publications

Sphenopalatine artery surgery for refractory idiopathic epistaxis: Systematic review and meta‐analysis

Sphenopalatine artery surgery for refractory idiopathic epistaxis: Systematic review and meta‐analysis

Cost-effectiveness Analysis of Endoscopic Sphenopalatine Artery Ligation vs Arterial Embolization for Intractable Epistaxis

Epistaxis and New Approaches to the Management of Epistaxis: Review

Contact Info

Product

Resources

About